Granted Patent
B2
US 12,590,948 · App. 16/548,516 · Granted Mar 31, 2026
Systems and methods for discovery and analysis of markers
Inventors:
John T. Stults (Redwood City, CA); Alfred Greenquist (San Jose, CA); Alexander Sassi (Berkeley, CA)
Assignee:
SEER, INC.
G01N33/50A61B5/150755G01N27/26G16B40/00G16B40/10H01J49/0027H01J49/165G16B20/00H01J49/00Y02A90/10Y10T436/117497
View Patent ↗
Loading inventors, assignments & file history…
Abstract
A business method for use in classifying patient samples. The method includes steps of collecting case samples representing a clinical phenotypic state and control samples representing patients without said clinical phenotypic state. Preferably the system uses a mass spectrometry platform system to identify patterns of polypeptides in said case samples and in the control samples without regard to the specific identity of at least some of said polypeptides. Based on identified representative patterns of the state, the business method provides for the marketing of diagnostic products using representative patterns. The present invention relates to systems and methods for identifying new markers, diagnosing patients with a biological state of interest, and marketing/commercializing such diagnostics. The present invention relates to systems and methods of greater sensitivity, specificity, and/or cost effectiveness.
Claims (7)
1 . A system for analyzing biological samples comprising:
(a) a sample preparation device comprising a separation device, a sample ionizer, and an ion excitation device, wherein the separation device is configured to deplete a sample of highly abundant proteins that are present in the biological sample at a concentration of at least 10 μg/mL;
(b) a mass spectrometer coupled to said sample preparation device; and
(c) a switch coupled to said ion excitation device.
2 . A system for analyzing a biological sample comprising:
(a) a sample preparation device comprising a polypeptide denaturation device and a polypeptide removal device, wherein the sample preparation device is configured to deplete a sample of highly abundant proteins that are present in the biological sample at a concentration of at least 10 μg/mL; and
(b) a sample analysis device comprising a mass spectrometer, wherein said sample analysis device is configured to identify at least one biological marker of interest in said biological sample when the at least one biological marker is bound to a polypeptide that is removed in said polypeptide removal device.
Assignments (5)
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded Apr 29, 2020
From: STULTS, JOHN T.; GREENQUIST, ALFRED; SASSI, ALEXANDER
To: PREDICANT BIOSCIENCES, INC.
Reel/Frame 052524/0928 →
CHANGE OF NAME
Recorded Apr 29, 2020
From: PREDICANT BIOSCIENCES, INC.
To: PATHWORK DIAGNOSTICS, INC.
Reel/Frame 052525/0253 →
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded Apr 29, 2020
From: PATHWORK DIAGNOSTICS, INC.
To: NORVIEL, VERN
Reel/Frame 052530/0487 →
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded Apr 29, 2020
From: NORVIEL, VERN
To: SEER BIOSCIENCES, INC.
Reel/Frame 052530/0537 →
CHANGE OF NAME
Recorded Apr 29, 2020
From: SEER BIOSCIENCES, INC.
To: SEER, INC.
Reel/Frame 052531/0947 →
Continuity (10)
Provisional Application
60473272
· May 22, 2003
References Cited (345)
US 4443319A
· Chait et al.
· 1984
[cited by applicant]
US 4483885A
· Chait et al.
· 1984
[cited by applicant]
US 4977320A
· Chowdhury et al.
· 1990
[cited by applicant]
US 5045694A
· Beavis et al.
· 1991
[cited by applicant]
US 5227471A
· Wright, Jr.
· 1993
[cited by applicant]
US 5245186A
· Chait et al.
· 1993
[cited by applicant]
US 5296114A
· Manz
· 1994
[cited by applicant]
US 5314996A
· Wright, Jr.
· 1994
[cited by applicant]
US 5358618A
· Ewing et al.
· 1994
[cited by applicant]
US 5393975A
· Hail et al.
· 1995
[cited by applicant]
US 5545304A
· Smith et al.
· 1996
[cited by applicant]
US 5599432A
· Manz et al.
· 1997
[cited by applicant]
US 5624539A
· Ewing et al.
· 1997
[cited by applicant]
US 5639656A
· Wright, Jr.
· 1997
[cited by applicant]
US 5652427A
· Whitehouse et al.
· 1997
[cited by applicant]
US 5788166A
· Valaskovic et al.
· 1998
[cited by applicant]
US 5833861A
· Afeyan et al.
· 1998
[cited by applicant]
US 5856671A
· Henion et al.
· 1999
[cited by applicant]
US 5872010A
· Karger et al.
· 1999
[cited by applicant]
US 5917184A
· Carson et al.
· 1999
[cited by applicant]
US 5928952A
· Hutchins et al.
· 1999
[cited by applicant]
US 5952653A
· Covey et al.
· 1999
[cited by applicant]
US 5958202A
· Regnier et al.
· 1999
[cited by applicant]
US 5993633A
· Smith et al.
· 1999
[cited by applicant]
US 6007989A
· West
· 1999
[cited by examiner]
US 6017537A
· Alexander
· 2000
[cited by examiner]
US 6017693A
· Yates, III et al.
· 2000
[cited by applicant]
US 6025136A
· Drmanac
· 2000
[cited by applicant]
US 6033546A
· Ramsey
· 2000
[cited by applicant]
US 6068749A
· Karger et al.
· 2000
[cited by applicant]
US 6086243A
· Paul et al.
· 2000
[cited by applicant]
US 6091502A
· Weigl et al.
· 2000
[cited by applicant]
US 6107628A
· Smith et al.
· 2000
[cited by applicant]
US 6139734A
· Settlage et al.
· 2000
[cited by applicant]
US 6140468A
· Vihko
· 2000
[cited by applicant]
US 6157921A
· Barnhill
· 2000
[cited by applicant]
US 6159739A
· Weigl et al.
· 2000
[cited by applicant]
US 6175112B1
· Karger et al.
· 2001
[cited by applicant]
US 6187190B1
· Smith et al.
· 2001
[cited by applicant]
US 6207370B1
· Little et al.
· 2001
[cited by applicant]
US 6207954B1
· Andrien, Jr. et al.
· 2001
[cited by applicant]
US 6225047B1
· Hutchens et al.
· 2001
[cited by applicant]
US 6231737B1
· Ramsey et al.
· 2001
[cited by applicant]
US 6240790B1
· Swedberg et al.
· 2001
[cited by applicant]
US 6277641B1
· Yager
· 2001
[cited by applicant]
US 6280589B1
· Manz et al.
· 2001
[cited by applicant]
US 6284113B1
· Bjornson et al.
· 2001
[cited by applicant]
US 6284115B1
· Apffel
· 2001
[cited by applicant]
US 6306087B1
· Barnhill et al.
· 2001
[cited by applicant]
US 6309816B1
· Zhang et al.
· 2001
[cited by applicant]
US 6318970B1
· Backhouse
· 2001
[cited by applicant]
US 6322682B1
· Arvidsson et al.
· 2001
[cited by applicant]
US 6329209B1
· Wagner et al.
· 2001
[cited by applicant]
US 6342142B1
· Ramsey
· 2002
[cited by applicant]
US 6358692B1
· Jindal et al.
· 2002
[cited by applicant]
US 6363383B1
· Kindo et al.
· 2002
[cited by applicant]
US 6368562B1
· Yao
· 2002
[cited by applicant]
US 6375817B1
· Taylor et al.
· 2002
[cited by applicant]
US 6379791B1
· Cernohous et al.
· 2002
[cited by applicant]
US 6379971B1
· Schneider et al.
· 2002
[cited by applicant]
US 6413780B1
· Bach et al.
· 2002
[cited by applicant]
US 6427141B1
· Barnhill
· 2002
[cited by applicant]
US 6558955B1
· Kristal et al.
· 2003
[cited by applicant]
US 6593298B2
· Jackowski et al.
· 2003
[cited by applicant]
US 6599877B2
· Jackowski et al.
· 2003
[cited by applicant]
US 6602855B2
· Jackowski et al.
· 2003
[cited by applicant]
US 6617308B2
· Jackowski et al.
· 2003
[cited by applicant]
US 6620786B2
· Jackowski et al.
· 2003
[cited by applicant]
US 6620787B2
· Jackowski et al.
· 2003
[cited by applicant]
US 6627606B2
· Jackowski et al.
· 2003
[cited by applicant]
US 6627607B2
· Jackowski et al.
· 2003
[cited by applicant]
US 6627608B2
· Jackowski et al.
· 2003
[cited by applicant]
US 6658395B1
· Barnhill
· 2003
[cited by applicant]
US 6675104B2
· Paulse et al.
· 2004
[cited by applicant]
US 6677303B2
· Jackowski et al.
· 2004
[cited by applicant]
US 6703366B2
· Jackowski et al.
· 2004
[cited by applicant]
US 6714925B1
· Barnhill et al.
· 2004
[cited by applicant]
US 6756476B2
· Jackowski et al.
· 2004
[cited by applicant]
US 6855251B2
· Moon et al.
· 2005
[cited by applicant]
US 6858842B2
· Moon et al.
· 2005
[cited by applicant]
US 6863790B1
· Moini et al.
· 2005
[cited by applicant]
US 7007710B2
· Heller et al.
· 2006
[cited by applicant]
US 7105812B2
· Zhao et al.
· 2006
[cited by applicant]
US 7425700B2
· Stults et al.
· 2008
[cited by applicant]
US 7460960B2
· Lee et al.
· 2008
[cited by applicant]
US 7906758B2
· Stults et al.
· 2011
[cited by applicant]
US 20010014461A1
· Hutchens et al.
· 2001
[cited by applicant]
US 20010041357A1
· Fouillet et al.
· 2001
[cited by applicant]
US 20010044104A1
· Warrington et al.
· 2001
[cited by applicant]
US 20010044151A1
· Carlson
· 2001
[cited by examiner]
US 20020009394A1
· Koster et al.
· 2002
[cited by applicant]
US 20020010552A1
· Rienhoff et al.
· 2002
[cited by applicant]
US 20020036140A1
· Manz et al.
· 2002
[cited by applicant]
US 20020039747A1
· Lubman et al.
· 2002
[cited by applicant]
US 20020041827A1
· Yager et al.
· 2002
[cited by applicant]
US 20020048777A1
· Ali et al.
· 2002
[cited by applicant]
US 20020054289A1
· Thibault et al.
· 2002
[cited by applicant]
US 20020095260A1
· Huyn
· 2002
[cited by applicant]
US 20020119490A1
· Aebersold et al.
· 2002
[cited by applicant]
US 20020127237A1
· Salceda et al.
· 2002
[cited by applicant]
US 20020127727A1
· Bach et al.
· 2002
[cited by applicant]
US 20020137086A1
· Olek et al.
· 2002
[cited by applicant]
US 20020138208A1
· Paulse et al.
· 2002
[cited by applicant]
US 20020142481A1
· Andersson et al.
· 2002
[cited by applicant]
US 20020177140A1
· Salceda et al.
· 2002
[cited by applicant]
US 20020193950A1
· Gavin et al.
· 2002
[cited by applicant]
US 20030004402A1
· Hitt et al.
· 2003
[cited by applicant]
US 20030013120A1
· Patz et al.
· 2003
[cited by applicant]
US 20030032043A1
· Pohl et al.
· 2003
[cited by applicant]
US 20030039983A1
· Sun et al.
· 2003
[cited by applicant]
US 20030064377A1
· Sun et al.
· 2003
[cited by applicant]
US 20030077611A1
· Slepnev
· 2003
[cited by applicant]
US 20030078739A1
· Norton et al.
· 2003
[cited by applicant]
US 20030089605A1
· Timperman
· 2003
[cited by applicant]
US 20030106797A1
· Schneider
· 2003
[cited by examiner]
US 20030111596A1
· Becker et al.
· 2003
[cited by applicant]
US 20030129760A1
· Aguilera et al.
· 2003
[cited by applicant]
US 20030132114A1
· Mischak et al.
· 2003
[cited by applicant]
US 20030134304A1
· Van et al.
· 2003
[cited by applicant]
US 20030144483A1
· Tempest
· 2003
[cited by examiner]
US 20030148295A1
· Wan et al.
· 2003
[cited by applicant]
US 20030148922A1
· Knapp et al.
· 2003
[cited by applicant]
US 20030153007A1
· Chen et al.
· 2003
[cited by applicant]
US 20030175707A1
· Sun et al.
· 2003
[cited by applicant]
US 20030194739A1
· Ali et al.
· 2003
[cited by applicant]
US 20030199001A1
· Pitt et al.
· 2003
[cited by applicant]
US 20030224531A1
· Brennen et al.
· 2003
[cited by applicant]
US 20030228639A1
· Wright et al.
· 2003
[cited by applicant]
US 20040005634A1
· Patz et al.
· 2004
[cited by applicant]
US 20040018519A1
· Wright, Jr.
· 2004
[cited by applicant]
US 20040029194A1
· Parish et al.
· 2004
[cited by applicant]
US 20040033591A1
· Lubman et al.
· 2004
[cited by applicant]
US 20040043436A1
· Vlahou et al.
· 2004
[cited by applicant]
US 20040053333A1
· Hitt et al.
· 2004
[cited by applicant]
US 20040075050A1
· Rossier et al.
· 2004
[cited by applicant]
US 20040153249A1
· Zhang et al.
· 2004
[cited by applicant]
US 20040180380A1
· Lee et al.
· 2004
[cited by applicant]
US 20040235052A1
· Heller et al.
· 2004
[cited by applicant]
US 20040236603A1
· Heller et al.
· 2004
[cited by applicant]
US 20050059013A1
· Chan et al.
· 2005
[cited by applicant]
US 20050072915A1
· Stults et al.
· 2005
[cited by applicant]
US 20050244973A1
· Andel, III et al.
· 2005
[cited by applicant]
US 20060027744A1
· Stults et al.
· 2006
[cited by applicant]
US 20060186048A1
· Tan
· 2006
[cited by applicant]
US 20060186049A1
· Boyes et al.
· 2006
[cited by applicant]
US 20070009970A1
· Heller et al.
· 2007
[cited by applicant]
US 20090057550A1
· Stults et al.
· 2009
[cited by applicant]
US 20110315552A1
· Stults et al.
· 2011
[cited by applicant]
US 20120046184A1
· Dawson et al.
· 2012
[cited by applicant]
US 20120328594A1
· McKenna et al.
· 2012
[cited by applicant]
US 20130052661A1
· Huo
· 2013
[cited by applicant]
US 20130058923A1
· Huo
· 2013
[cited by applicant]
US 20140374584A1
· Stults et al.
· 2014
[cited by applicant]
US 20170074869A1
· Krijgsveld et al.
· 2017
[cited by applicant]
US 20170328885A1
· Stults et al.
· 2017
[cited by applicant]
US 20210132071A1
· Kostarelos et al.
· 2021
[cited by applicant]
EP 0881494A1
· 1998
[cited by applicant]
EP 1512970A1
· 2005
[cited by applicant]
EP 3510402A1
· 2019
[cited by applicant]
WO WO9525281A1
· 1995
[cited by applicant]
WO WO0023111A1
· 2000
[cited by applicant]
WO WO0063683A1
· 2000
[cited by applicant]
WO WO0065472A1
· 2000
[cited by applicant]
WO WO0125791A2
· 2001
[cited by applicant]
WO WO0136977A2
· 2001
[cited by applicant]
WO WO0157263A1
· 2001
[cited by applicant]
WO WO0157518A2
· 2001
[cited by applicant]
WO WO0171360A2
· 2001
[cited by applicant]
WO WO0204957A2
· 2002
[cited by applicant]
WO WO0206829A2
· 2002
[cited by applicant]
WO WO0208760A1
· 2002
[cited by applicant]
WO WO0227329A2
· 2002
[cited by applicant]
WO WO0246448A2
· 2002
[cited by applicant]
WO WO02097703A2
· 2002
[cited by applicant]
WO WO03014302A2
· 2003
[cited by applicant]
WO WO03031031A1
· 2003
[cited by applicant]
WO WO03038055A2
· 2003
[cited by applicant]
WO WO03042774A2
· 2003
[cited by applicant]
WO WO03057014A2
· 2003
[cited by applicant]
WO WO03058198A2
· 2003
[cited by applicant]
WO WO03072710A2
· 2003
[cited by applicant]
WO WO03083442A2
· 2003
[cited by applicant]
WO WO03086445A1
· 2003
[cited by applicant]
WO WO03089937A2
· 2003
[cited by applicant]
WO WO03091695A2
· 2003
[cited by applicant]
WO WO03097799A2
· 2003
[cited by applicant]
WO WO2004012588A2
· 2004
[cited by applicant]
WO WO2004013609A2
· 2004
[cited by applicant]
WO WO2004030511A2
· 2004
[cited by applicant]
WO WO2004055519A2
· 2004
[cited by applicant]
WO WO2004061407A2
· 2004
[cited by applicant]
WO WO2004061410A2
· 2004
[cited by applicant]
WO WO2004068130A2
· 2004
[cited by applicant]
WO WO2004102190A1
· 2004
[cited by applicant]
WO WO2005011474A2
· 2005
[cited by applicant]
WO WO2005020125A2
· 2005
[cited by applicant]
WO WO2005024409A1
· 2005
[cited by applicant]
WO WO2010097785A1
· 2010
[cited by applicant]
WO WO2011088128A2
· 2011
[cited by applicant]
Prostate Specific Antigen (PSA) Free (Unbound). The University of Iowa, Department of Pathology. Laboratory Services Handbook, 2 pages. (Year: 2021).
[cited by examiner]
What is the molecular weight (mw) of Immunoglobulin G (IgG)?. AAT Bioquest. Frequently Asked Questions, 2 pages. (Year: 2018).
[cited by examiner]
Rijsselaere et al. Effect of centrifugation on in vitro survival of fresh diluted canine spermatozoa. Theriogenology. vol. 57, pp. 1669-1681. (Year: 2002).
[cited by examiner]
Adam et al. Serum Protein Fingerprinting Coupled with a Pattern-matching Algorithm Distinguishes Prostate Cancer from Benign Prostate Hyperplasia and Healthy Men. Cancer Research. 2002;62:3609-3614.
[cited by applicant]
Adkins, Joshua N., et al., “Toward a human blood serum proteome: analysis by multidimensional separation coupled with mass spectrometry”. The American Society for Biochemistry and Molecular Biology, Inc., MCP Paper (Nov…
[cited by applicant]
Anderson, et al. A comparison of selected mRNA and protein abundances in human liver. Electrophoresis. Mar.-Apr. 1997;18(3-4):533-7.
[cited by applicant]
Anderson, et al. The Human Plasma Proteome, Molecular & Cellular Proteomics, 2002, 845-867.
[cited by applicant]
Auriola, Seppo et al., “Enhancement of sample loadings for the analysis of oligosaccharides isolated from Pseudomonas aeruginosa using transient isotachophoresis-electrospray-mass spectrometry”. Electrophoresis (1998), …
[cited by applicant]
Banez, Lionel L., et al., “Diagnostic potential of serum proteomic patterns in prostate cancer”. The Journal of Urology (2003) 170:442-446.
[cited by applicant]
Belov et al. “Dynamic range expansion applied to mass spectrometry based on data-dependent selective ion ejection in capillary liquid chromatography Fourier transfrom ion cyclotron resonance for enhanced proteome charac…
[cited by applicant]
Bertero, M., “Linear inverse and ill-posed problems”. In Advances in Electronics and Electronic Physics. Academic Press (1989), NY.
[cited by applicant]
Billingsley, Janice, “Research offers hope in fight against ovarian cancer”. Health & Science (Feb. 8, 2002) 3 pages.
[cited by applicant]
Brocket al. Hadamard transform time-of-flight mass spectrometry. Analytical Chemistry, vol. 70, 1998, pp. 3735-3741.
[cited by applicant]
Cao, Ping et al., “Analysis ofpeptides, proteins, protein digests, and whole human blood by capillary electrophoresis/electrospray ionization-mass spectrometry using an in-capillary electrode sheath less interface”. J A…
[cited by applicant]
Cazares, L. H., et al., “Normal, benign, preneoplastic, and malignant prostate cells have distinct protein expression profiles resolved by surface enhanced laser desorption/ionization mass spectromety”. Clinical Cancer …
[cited by applicant]
CBS News, “Setback for a silent killer”. CBS News.com (Apr. 2, 2002), 2 pages.
[cited by applicant]
Chambers, et al., “Proteomics: A New Approach to the Study of Disease”. Journal of Pathology 2000; 192:280-288.
[cited by applicant]
Chen, S. S. et al. “Atomic decomposition by basis pursuit”. SIAM Journal on Scientific Computing, (1988), 20(1):33-61.
[cited by applicant]
Covey, Thomas R., et al., “Structural characterization of protein tryptic peptides liquid via chromatography/mass spectrometry and collision-induced dissociation of their doubly charged molecular ions”. Anal. Chern. (19…
[cited by applicant]
CRISP—Computer retrieval of information on scientific projects [abstract], << http://commons.clt.nlh.gov/crisp3/CRISPLIB.getdoc?textkey=63 88327&pgrant_num=5RO1HG002033-03&p_query=&ticket= . . . >> . Downloaded May 9, 2…
[cited by applicant]
Diamandis, Eleftherios P., “Point proteomic patterns in biological fluids: do they represent the future of cancer diagnostics?”. Clinical Chemistry (2003) 49(8) 1272-1278.
[cited by applicant]
Donoho, D. L “Unconditional bases are optimal bases for data compression and for statistical estimation”. Applied and Computational Harmonic Analysis, (1993), 1(1):100-115.
[cited by applicant]
Donoho, D. L. “Nonlinear solution of linear inverse problems by waveletvaguelette decomposition”. App. and Comp. Harmonic Analysis, (1995), 2:101-126.
[cited by applicant]
Donoho, D. L., et al. “Adapting to unknown smoothness via wavelet shrinkage”. Journal of the American Statistical Association, (1995), 90(432): 1200-1224.
[cited by applicant]
Editorial, “Proteomic diagnostics tested”. Nature (Jun. 3, 2004), 429(3), 487.
[cited by applicant]
Etzioni, et al. The Case for Early Detection. Nature Reviews—Cancer, 3:1-10 (Apr. 2003).
[cited by applicant]
Etzioni, Ruth, et al., “Combining biomarkers to detect disease with application to prostate cancer”. Biostatistics (2003), 4(4), 523-538.
[cited by applicant]
European search report dated Dec. 30, 2005 for EP Application No. 04252996.
[cited by applicant]
Ferrucci JT. Colon screening with virtual colonoscopy: Promise, Polyps, Politics. AJR, vol. 177, 2001, pp. 975-988.
[cited by applicant]
Figeys, Daniel et al., “High sensitivity analysis of proteins and peptides by capillary electrophoresis-tandem mass spectrometry: recent developments in technology and applications”. Electrophoresis, (1998), 19:885-892.
[cited by applicant]
Fung, Eric T., et al., “Classification of cancer types by measuring variants of host response proteins using SELDI serum assays,” Int. J. Cancer (2005) 115:783-789.
[cited by applicant]
Fung, et al. ProteinChip(R) clinical proteomics: Computational challenges and solutions. Biotechniques. 2002; 32(3): S34-S41.
[cited by applicant]
Geracimos, A., “Outwitting Ovarian Cancer”. Cone1ogic Systems, Inc., Press Release dated Apr. 16, 2002, 4 pages.
[cited by applicant]
Geromanos, S., et al., “Injection adaptable Fine Ionization Source (‘JaFIS’) for Continuous Flow Nano-electrospray”. Rapid Commun. Mass Spectrom (1998) 12:551-556.
[cited by applicant]
Guo, Xu et al., “Analysis of metallonthioneins by means of capillary electrophoresis coupled to electrospray mass spectrometry with sheathless interfacing” Rapid Commun. Mass Spectrom. (1999), 13:500-507.
[cited by applicant]
Guyon, I, et al. “An introduction to variable and feature selection”. JMLR, (2003), 1:1-48.
[cited by applicant]
Gygi, et al. Correlation between protein and mRNA abundance in yeast. Mol Cell Biol. Mar. 1999;19(3):1720-30.
[cited by applicant]
Hadjidemetriou, et al., A novel scavenging tool for cancer biomarker discovery based on the blood-circulating nanoparticle protein corona. Biomaterials. Jan. 2019; vol. 188: pp. 118-129.
[cited by applicant]
Hadjidemetriou, et al., In Vivo Biomolecule Corona around Blood-Circulating, Clinically Used and Antibody-Targeted Lipid Bilayer Nanoscale Vesicles. ACS Nano, 2015; 9(8): pp. 8142-8156.
[cited by applicant]
Hadjidemetriou, et al., The Human In Vivo Biomolecule Corona onto PEGylated Liposomes: A Proof-of-Concept Clinical Study. Advanced Materials. Nov. 28, 2018:e1803335. doi: 10.1002/adma.201803335. [Epub ahead of print].
[cited by applicant]
Haran, Christine, “The promise of proteins—Do these tricky molecules hold the answers to cancer?”. (Oct. 2002) 43-47.
[cited by applicant]
Harrison, Harold H., et al., “Multiple serum protein abnormalities in carbohydrate-deficient glycoprotein syndrome: pathognomomic finding of two-dimensional electrophoresis?”. Clinical Chemistry (1992), 38: 1390-1392.
[cited by applicant]
Hayes, Roger N., et al. “Collision-Induced Dissociation”. Methods in Enzymology, (1990), vol. 193, pp. 237-263.
[cited by applicant]
Henry, Celia, “Diagnosing ovarian cancer—Proteomics shows promise of early detection of deadly disease”. Science (Feb. 18, 2003) 18.
[cited by applicant]
Henzel et al. Identifying proteins from two-dimensional gels by molecular mass searching of peptide fragments in protein sequence databases. PNAS, 1993, vol. 90, pp. 5011-5015.
[cited by applicant]
Hilario, Melanie, et al., “Machine learning approaches to lung cancer prediction from mass spectra”. Protoemics (2003) 3:1716-1719.
[cited by applicant]
Hollon, Tom “Software Zeroes in on ovarian cancer”. The Scientist (Apr. 15, 2002) 16(8):16.
[cited by applicant]
Johannes, Laura, “Tiny protein may lead to better screen test for prostate cancer”. Dow Jones (Nov. 4, 2003), 1-2.
[cited by applicant]
Kaiser, Thorsten et al., “Capillary electrophoresis coupled to mass spectrometer for automated and robust polypeptide determination in body fluids for clinical use”. Electrophoresis (2004), 25:2044-2055.
[cited by applicant]
Kaiser, Thorsten et al., “Capillary electrophoresis coupled to mass spectrometry to establish polypeptide patterns in dialysis fluids”. Journal of Chromatography A (2003 ), 1013:157-171.
[cited by applicant]
Kajit A, Yoshihiro, et al., “Clinical Study on Increased Serum Thyroxine-Binding Globulin in Cancerous State,” Endocrinol. Japon (1981) 28 (6): 785-791.
[cited by applicant]
Kalif A, Jerome, et al., “Thresholding estimators for linear inverse problems and deconvolutions”. Annals of Statistics (2003), 1:58-109.
[cited by applicant]
Kalifa, Jerome, et al., “Minimax deconvolution in mirror wavelet bases”.IEEE Trans. on Image Processing (1999), 1-30.
[cited by applicant]
Koo et al., Amyloid diseases: abnormal protein aggregation in neurodegeneration Proc. Natl. Acad. Sci. U.S. A 96:9989-9990, 1999.
[cited by applicant]
Kundin, W.D., et al., “Cancer Serum Index: A useful Nonspecific Test as a Parameter in Multimodality Screening and Assessment of Patients With Cancer of the Prostate,” The Prostate (1981) 2:207-217.
[cited by applicant]
Lehrer, S., et al., “Putative protein markers in the sera of men with prostatic neoplasms”. BJU International (2003) 92:223-225.
[cited by applicant]
Levine, Peter, “Correlogic's ovarian cancer test nears market introduction”. Diagnostic Testing and Technology Report (Jul. 2003) 1:5-7.
[cited by applicant]
Li, et al. “Proteomics and Bioinformatics approaches for identification of serum biomakers to detect breast cancer”. Clinical Chemistry. 2002; 48(8): 1296-1304.
[cited by applicant]
Li, Jinong et al., “Detection of prostate cancer using serum proteomics pattern in a histologically confirmed population”. The Journal of Urology (May 2004), 171:1782-1787.
[cited by applicant]
Liotta, Lance, A., et al., “Written in Blood”. Nature, (Oct. 30, 2003), vol. 425, p. 905.
[cited by applicant]
Markey, Mia K., et al. “Decision tree classification of proteins identified by mass spectrometry of blood serum samples from people with and without lung cancer” Proteomics (2003) 3:1678-1679.
[cited by applicant]
Marshall, John, et al., “Processing of serum proteins underlies the mass spectral fingerprinting of myocardial infraction”. Journal of Proteome Research (Jan. 20, 2003) 12 pages.
[cited by applicant]
Mian, Shahid, et al., “A prototype methodology combining surface-enhanced laser desorption/ionization protein chip technology and artificial neural network algorithms to predict the chemoresponsiveness of breast cancer …
[cited by applicant]
Miller, et al. “Antibody microarray profiling of human prostate cancer sera: Antibody screening and identification of potential biomarkers.” Proteomics. vol. 3, pp. 56-63, (2003).
[cited by applicant]
Mobley, J.A., et al., “Monitoring The Serological Proteome: The Latest Modality in Prostate Cancer Detection,” The Journal of Urology (Jul. 2004) vol. 172: 331-337.
[cited by applicant]
Neuhoff, et al. “Mass spectrometry for the detection of differentially espressed proteins: a comparison of surface-enhanced laser desorption/ionization and capillay electrophoresis/mass spectrometry”. Rapid Cornmun. Mas…
[cited by applicant]
Neusub, Christian et al., “A robust approach for the analysis of peptides in the low femtomole range by capillary electrophoresis-tandem mass spectrometry”. Electrophoresis (2002), 23:3149-3159.
[cited by applicant]
Neville, Padraic, et al., “Generalizable mass spectrometry mining used to identify disease state biomarkers from blood serum”. Proteomics (2003) 3:1710-1715.
[cited by applicant]
Notice of Allowance dated Apr. 2, 2008 for U.S. Appl. No. 11/178,262.
[cited by applicant]
Notice of Allowance dated Nov. 1, 2010 for U.S. Appl. No. 12/172,988.
[cited by applicant]
Office action dated Jan. 26, 2005 for U.S. Appl. No. 10/645,863.
[cited by applicant]
Office action dated Feb. 1, 2007 for U.S. Appl. No. 10/760,100.
[cited by applicant]
Office action dated Feb. 10, 2012 for U.S. Appl. No. 13/018,622.
[cited by applicant]
Office action dated Mar. 2, 2016 for U.S. Appl. No. 14/166,626.
[cited by applicant]
Office action dated Apr. 19, 2005 for U.S. Appl. No. 10/645,863.
[cited by applicant]
Office action dated Jun. 15, 2005 for U.S. Appl. No. 10/645,863.
[cited by applicant]
Office action dated Jun. 23, 2016 for U.S. Appl. No. 14/166,626.
[cited by applicant]
Office Action dated Sep. 26, 2007 for U.S. Appl. No. 11/178,262.
[cited by applicant]
Office action dated Dec. 31, 2012 for U.S. Appl. No. 13/018,622.
[cited by applicant]
Ornstein, David K., et al., “Serum Proteomic Profiling Can Discriminate Prostate Cancer From Benign Prostates in Men With Total Prostate Specific Antigen Levels Between 2.5 And 15.0 NG/ML,” The Journal of Urology (Oct. …
[cited by applicant]
Paroni, Rita et al., “Creatinine determination in serum by capillary electrophoresis”. Electrophoresis (2004), 25:463-468.
[cited by applicant]
Patterson, S.D., Proteomics: the industrialization of protein chemistry. Current Opinion in Biotechnology, 2000; 11: 413-418.
[cited by applicant]
Petri Coin III, E. F., et al., “Serum proteomic patterns for detection of prostate cancer”. JNCI (2002), 94(20):1576-1578.
[cited by applicant]
Petricoin III, E. F., et al., “Use of proteomic patterns in serum to identify ovarian cancer”. The Lancet (2002), 359:572-577.
[cited by applicant]
Purohit, Parol V., et al., “Discriminant models for high-throughput proteomics mass spectrometer data”. Proteomics (2003) 3: 1699-1703.
[cited by applicant]
Qu, Yinsheng, et al., “Boosted decision tree analysis of surface-enhanced laser desorption/ionization mass spectral serum profiles discriminates prostate cancer from noncancer patients”. Clinical Chemistry (2002), 48(10…
[cited by applicant]
Reddy, et al. “Seldi proteinchip(R) array technology: protein-based predictive medicine and drug discovery applications. Journal of Biomedicine & Biotechnology”. 2003; 2003 (4): 237-241.
[cited by applicant]
Reixach, et al. Tissue damage in the amyloidoses: Transthyretin monomers and nonnative oligomers are the major cytotoxic species in tissue culture. Proc Natl Acad Sci U S A. Mar. 2, 2004;101(9):2817-22. Epub Feb. 23, 20…
[cited by applicant]
RNA (ribonucleic acid), 1988. Illustrated Dictionary of Science, Andromeda. Retrieved online on Feb. 8, 2012<< http://www.credoreference.com/etry/andidsci/rna_ribonucleic_acid>>.
[cited by applicant]
Robey, Edwin L., et al., “Cancer Serum Index And Prostatic Acid Phosphatase For Detection Of Progressive Prostatic Cancer,” The Journal of Urology (Oct. 1985) vol. 134: 787-790.
[cited by applicant]
Rohde, E. et al., “Comparison of protein mixtures in aqueous humor by membrane preconcentration—capillary electrophoresis—mass spectrometry”. Electrophoresis (1998), 19:2361-2370.
[cited by applicant]
Rostenberg, Israel, et al., “Gc Globulin and Prealbumin Serum Levels in Patients With Cancer and Benign Inflammatory Diseases and in Asymptomatic Smokers,” Journal of the National Cancer Institute (Feb. 1997) vol. 62 No…
[cited by applicant]
Rubin, Rita, “Blood test may spot ovarian cancer earlier” Health & Science (Feb. 8, 2002) 2 pages.
[cited by applicant]
Rui, et al., Use of serological proteomic methods to find biomarkers associated with breast cancer. Proteomics, Apr. 2003; 3(4): 433-439.
[cited by applicant]
Sassi, Alexander P., et al., “An automated, sheathless capillary electrophoresis-mass spectrometry platform for discovery of biomarkers in human serum”. Electrophoresis (2005), 26:pages unknown.
[cited by applicant]
Schultz, Gary A. et al., “Development of a proteome marker model for ovarian cancer using direct analysis of diluted serum by automated nanoelectrospray TOFMS” ASMS (2003) 2 pages.
[cited by applicant]
Schweigert, Florian J., et al., “Transthyretin, a Biomarker for Nutritional Status and Ovarian Cancer,” Cancer Research (Feb. 1, 2005) 65 (3): 1114.
[cited by applicant]
Service, R.F., “Recruiting genes, proteins for a revolution in diagnostics”. Science (Apr. 11, 2003), 300:236-239.
[cited by applicant]
Silva, Chris, “Small company, big partners—Bethesda-based Correlogic Systems enlists allies in quest to bring its concern detection test to market” Washington Business Journal (Aug. 30-Sep. 5, 2002) 2 pages.
[cited by applicant]
Singh, et al. “Gene expression correlates of clinical prostate cancer behavior.” Cancer Cell. vol. 1, pp. 203-209 (2002).
[cited by applicant]
Somorjai, R. L., et al., “Class prediction and discovery using gene microarray and proteomics mass spectroscopy data: cruses, caveats, cautions”. Bioinfomatrics (2003) 19(12): 1484-1491.
[cited by applicant]
Sorace, James M., et al., “A data review and re-assessment of ovarian cancer serum proteomic profiling”. BMC Bioinformatics (2003) 4(24):1-13.
[cited by applicant]
Sorlie et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. PNAS USA 98:10869-10874 (2001).
[cited by applicant]
Srinivas, et al., Proteomics for Cancer Biomarker Discovery. Clinical Chemistry, Aug. 2002; 48(8): 1160-1169.
[cited by applicant]
Strand, O. N. “Theory and methods related to the singular function expansion and landweber's iteration for integral equations of the first kind”. SIAM J. Num. Anal., (1973), 798-825.
[cited by applicant]
Strittmatter, E. F., et al., “High mass measurement accuracy determination for proteomics using multivariate regression fitting: application to electrospray ionization time-of-flight mass spectrometry”. Anal. Chern., (2…
[cited by applicant]
Stroink, Thorn et al., “On-line coupling of size exclusion and capillary zone electrophoresis via a reversed-phase Cl8 trapping col. for the analysis of structurally related enkephalines in cerebrospinal fluid”. Electro…
[cited by applicant]
Svedberg, Malin et al., “Sheathless Electrospray from Polymer Microchips”, Analytical Chemistry, vol. 75, No. 15, Aug. 1, 2003, pp. 3934-3940.
[cited by applicant]
Tatay, Jacob W., “Multiple approaches to data-mining of proteomic data based on statistical and pattern classification methods”. Proteomics (2003) 3: 1704-1709.
[cited by applicant]
Thompson, Ian M., et al., “Prevalence of Prostate Cancer among Men with a Prostate-Specific Antigen Level 4.0 ng per Milliliter,” The New England Journal of Medicine (May 27, 2004) vol. 350 No. 22: 2239-2246.
[cited by applicant]
Tibshirani. Regression shrinkage and selection via the lasso. Journal of the Royal Statistical Society Series B (Methodological) 58:267-288 (1996).
[cited by applicant]
Tihonov, A. N., “Solution of incorrectly formulated problems and the regularization method”. Soviet Math. Doklady (1963), 4: 1035-1038.
[cited by applicant]
Tirumalai, Radhakrishna S. et al., “Characterization of the low molecular weight human serum proteome”, Molecular & Cellular Proteomics 2.10 (Aug. 13, 2003), 1096-1103.
[cited by applicant]
Touchetie, Nancy, “Diagnosing Ovarian Cancer by Proteomics”. Genome News Network (2003), 2 pages.
[cited by applicant]
U.S. Appl. No. 15/388,954 Office Action dated May 15, 2019.
[cited by applicant]
U.S. Appl. No. 16/132,076 Notice of Allowance dated Jul. 2, 2019.
[cited by applicant]
U.S. Appl. No. 16/132,076 Office Action dated Feb. 12, 2019.
[cited by applicant]
Van 'T Veer et al. Gene expression profiling predicts clinical outcome of breast cancer. Nature 415(6871):530-536 (2002).
[cited by applicant]
Vejda, Susanne, et al., “Plasma from Cancer Patients Featuring a Characteristic Protein Composition Mediates Protection against Apoptosis,” Molecular & Cellular Proteomics (2002):387-393.
[cited by applicant]
Vestal, M., et al., “Resolution and mass accuracy in matrix-assisted laser desorption ionization-time-of-flight”. J. Am. Soc. Mass Spectrom (1998), 9:892-911.
[cited by applicant]
Villanueva, Josep et al., “Serum peptide profiling by magnetic particle-assisted, automated sample processing and MALDI-TOF mass spectrometry”. Anal. Chern. (Mar. 15, 2004), 76(6): 1560-1570.
[cited by applicant]
Vlahou, Antonia, et al., “Development of a novel proteomic approach for the detection of transitional cell carcinoma of the bladder in urine”. American Journal of Pathology (Apr. 2001), 158(4): 1491-1502.
[cited by applicant]
Vohradsky, J., “Adaptive classification of two-dimensional gel electrophoretic spot patterns by neural networks and cluster analysis”. Electrophoresis (1997), 18:2749-2754.
[cited by applicant]
Wang, Michael Z. et al., “Analysis ofhuman serum proteins by liquid phase isoelectric focusing and matrix-assisted laser desorption/ionization-mass spectrometry”, Proteomics (2003), 3:1661-1666.
[cited by applicant]
Ward, A. Milford, et al., “Acute Phase Reactant proteins in Prostatic Cancer,” British Journal of Urology (1977), 49: 411-418.
[cited by applicant]
Wehofsky, M., et al. “Automated deconvolution and deisotoping of electrospray mass spectra”. J. Mass Spectrom., (2002), 37(2):223-229.
[cited by applicant]
Wehofsky, M., et al. “Isotopic deconvolution of matrix-assisted laser desorption/ionization mass spectra for substance class specific analysis of complex samples”, (2001), 7:39-46.
[cited by applicant]
Williams, Jon D., et al., “Using accurate mass electrospray ionization-time-of-flight mass spectrometry with in-source collision-induced dissociation to sequence peptide mixtures”. Journal of Chromatography A (2003) 102…
[cited by applicant]
Wittke, Stefan et al., “Determination of peptides and proteins in human urine with capillary electrophoresis-mass spectrometry, a suitable tool for the establishment of new diagnostic markers”. Journal of Chromatography…
[cited by applicant]
Wright et al. Proteinchip surface enhanced laser desorption/ionization (SELDI) mass spectrometry: a novel protein biochip technology for detection of prostate cancer biomarkers in complex protein mixtures. Prostate Canc…
[cited by applicant]
Wu, Baolin et al., “Comparison of statistical methods for classification of ovarian cancer using mass spectrometry data”, Bioinformatics (2003) 19(13):1636-1643.
[cited by applicant]
Wu, Shiaw-Lin, et al., “Targeted proteomics of low-level proteins in human plasma by LC/MSn: Using human growth hormone as a model system”. Journal ofProteome Research (2002):459-465.
[cited by applicant]
Y Anagisa W A, Kiyoshi, et al., “Proteomic patterns of tumour subsets in non-small-cell lung cancer”. The Lancet (Aug. 9, 2003), 362:433-439.
[cited by applicant]
Yasui, Yataka, et al., “A data-analytic strategy for protein biomarker discovery: profiling of high-dimensional proteomic data for cancer detection”. Biostatistics (2003) 4(3):449-463.
[cited by applicant]
Zhang, Zhen, et al., “Three Biomarkers Identified from Serum Proteomic Analysis for the Detection of Early Stage Ovarian Cancer,” Cancer Research (Aug. 15, 2004) 64:5882-5890.
[cited by applicant]
Zhu, Hongtu, et al. “Tree-based disease classification using protein data”. Proteomics (2003) 3:1673-1677.
[cited by applicant]
Zhu, Wei, et al. “Detection of cancer-specific markers amid massive mass spectral data”. PNAS (Dec. 9, 2003) 100(25):14666-14761.
[cited by applicant]
Colapicchioni, V. et al. Personalized liposome-protein corona in the blood of breast, gastric and pancreatic cancer patients. International Journal of Biochemistry and Cell Biology, 2015,75(11): 180-187.
[cited by applicant]
Hajipour, M. J. et al. Personalized disease-specific protein corona influences the therapeutic impact of graphene oxide. Nanoscale, 2015, 7(19): 8978-8994.
[cited by applicant]
Miotto G, et al. Protein corona as a proteome fingerprint: The example of hidden biomarkers for cow mastitis. Colloids Surf B Biointerfaces. 2016;140:40-49. doi:10.1016/j.colsurfb.2015.11.043.
[cited by applicant]
Schrittwieser, S. et al. Direct protein quantification in complex sample solutions by surface-engineered nanorod probes. Scientific Reports, 2017, 7(4752): https://doi.org/10.1038/s41598-017-04970-5.
[cited by applicant]
Bigbee et al., Tumor Markers and Immunodiagnosis. Holland-Frei Cancer Medicine, 6th edition Hamilton (ON):BC Decker; Chapter 13, pp. 209-220 (2003).
[cited by applicant]
Breiman, L., Random forests. Machine learning 45, 5-32 (2001).
[cited by applicant]
De Lathauwer, L., B. De Moor, J. Vandewalle, A multilinear singular value decomposition. SIAM journal on Matrix Analysis and Applications 21, 1253-1278 (2000).
[cited by applicant]
Liaw, Classification and regression by randomForest. R news 2, 18-22 (2002).
[cited by applicant]